1、2Healthcare Industry ReportExecutive SummaryIntroductionPrecision Medicine Landscape Recent Trends and InnovationsKey Legislation and PoliciesAccess and ReimbursementHow SGA Can HelpReferencesMethodologyCONTENTS0102030405060708093Healthcare Industry ReportThe world of Precision Medicine is truly tra

2、nsformative and a ground-breaking approach to healthcare that tailors treatments to individual patients genetic,environmental,and lifestyle variations.New devel-opments such as mutation specific therapies,immunotherapies,and chimeric antigen receptor T(CART)cell therapy can increase life expectancy

3、as well as quality of lifeThe journey of precision medicine,from the elucidation of Deoxyribo-nucleic acid(DNA)structure in 1953 to the approval of 26 personal-ized medicines by the US Food and Drug Administration(USFDA)in 2023,has been full of key milestones and innovations.Pharmacogenomics is a ke

4、y tool in precision medicine,which aims to improve patient care by matching medications to individual genet-ics.Recent enhancements in computing power and developments in quantum computing have given a boost to the development of preci-sion medicines.This has now led to more than 40%of all approvals

5、 in 2023 being precision medicine.Other innovations such as Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR),biomarkers,and Next Generation Se-quencing(NGS)have helped precision medicine to be more effective.The advent of Artificial Intelligence(AI)has helped uncover hidden associat

6、ions in genomic datasets helping clinicians to devise person-alized treatment plans for their patients.Key legislation and policies are highlighted.Various countries,includ-ing the US,the UK,Australia,Canada,India,and Israel are reviewed,providing a global perspective on the regulatory environment.A